Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273416
Status:
COMPLETED
Last Update Posted:
2006-08-24
First Post:
2006-01-04
Brief Title:
A Randomized Double Blind Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Randomized Double Blind Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses Of PF-00592379 On Erectile Function Using 100mg Sildenafil As A Positive Control
Status:
COMPLETED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary aim of this study is to assess how effective PF-00592379 is in restoring penile erections in patients with erectile dysfunction Patients will attend for 4 treatment visits where they will receive the following in random order 2 separate doses of PF-00592379 sildenafil 100mg used as a positive control or placebo dummy medication The effect on penile erections will be assessed in the clinic using penile plethysmography RigiScan PlusTM technique
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None